Newsroom

Kanza AI
Press & News

Official announcements, press releases, and media resources from Kanza AI.

Kanza AI Welcomes Aphelion Capital as an Investor

How a simple post in LinkedIn led to a rare venture deal.

It was an unusually severe weekend even for Dallas in June — with very heavy rain and thunderstorms. Patrick Wayte got up and a LinkedIn post1 caught his eye — Lightning AI announcing Kanza AI’s Clinical Reasoning System on NVIDIA infra2 and he immediately reached out to us saying congratulations on the announcement and we should chat.

We were not connected to Patrick, but his words carried a lot of meaning “We’ve been looking for a company like you for the last 4 years.” What was in that post that he was able to deeply understand what Kanza AI had secretly built?

That one decision led to some incredible outcomes in the last 4 months.

On June 1st, we had quietly launched our latest version on Dr. Jan Rydfors request to only invite the master physicians to use clinically. In just a few weeks, we knew we had something that was at the cutting edge of AI. Over our years at Apple, we had learned to recognize when a product has an inflection point.

Dr. Rydfors came to us with other unusual requests — that Kanza should not be a typical Silicon Valley company led only by tech given physicians were co-developing this with us — and asked if we could also have healthcare co-own a part of us. At the same time, Patrick also connected us to Aphelion Capital, who ran their own diligence process led by their venture capital team and physicians using the Kanza platform and also asked if they could invest.

Given our last round was back in December 2024, and unlike other Healthcare and AI labs, we had not yet announced any mega rounds, we did something rare – we decided to go back and topped up our Series A to say thank you.

Kanza AI welcomes Aphelion Capital as an investor along with physicians and healthcare insiders. This completes the Kanza AI designated reserve set aside for investments in its Series A, (December 2024) for healthcare organizations, leaders and physicians to share in helping build and invest in Kanza AI’s clinical reasoning intelligence platform.

So with so many startups and frontier labs all building 100’s of amazing healthcare AI products, what made Kanza with a small team build something that every physician like Dr Rydfors has used – say that Kanza is the best AI that is designed to think the way physicians work?

What did Patrick see in one post that led him to believe that Kanza had the makings to be an essential deep harness like Cursor or Harvey in Healthcare AI?

#KanzaAI #SeriesA #HealthcareAI #ClinicalAI #ReasoningAI #VentureCapital #FounderStory #AphelionCapital #FutureOfMedicine

 ·  For Immediate Release

Kanza AI joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

American Heart Association consortium advances development of evidence-based health tech solutions

Silicon Valley, October 8, 2026 — Kanza AI, the healthcare technology startup that has built the leading Clinical Reasoning System (CRS), has joined the American Heart Association Center for Health Technology & Innovation’s Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

The Innovators’ Network is a consortium connecting entrepreneurs, providers, researchers and payers to advance cardiovascular and brain health innovation. Innovators’ Network members also have the opportunity to access the Association’s digital evidence-based scientific guidelines and clinical recommendations as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including building models for clinical outcome studies, which lowers the significant cost of developing those studies independently, helping connect the science to technology and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.

“The Center aims to advance the rapid, efficient, and effective development of healthcare technology,” said Seth S. Martin, MD, MHS, FAHA, volunteer chair of the American Heart Association’s Health Tech Advisory Group for the Center and professor of medicine in the division of cardiology at Johns Hopkins University School of Medicine. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”

“Clinicians need more than just access to information. The challenge is determining what matters as the clinical picture develops to the moment of decision by a physician,” said Samir Arora, CEO of Kanza AI. “Kanza’s Clinical Reasoning System is designed to support clinicians through the decision process while keeping their independent judgment at its center. Joining the Innovators’ Network gives us the opportunity to significantly advance evidence-based health innovation to improve healthcare outcomes.”

About Kanza

Kanza joins the Innovators’ Network bringing its Clinical Reasoning System (CRS), a clinician-facing platform that supports healthcare professionals as they work through complex clinical questions and toward clinical decisions at the point of care.

Unlike documentation tools or medical search–retrieval engines, the Kanza CRS works a case using clinical reasoning — weighing evidence, flagging where it’s uncertain, and citing every step so its reasoning is auditable and reproducible. As the physician evaluates the case, Kanza CRS presents the basis for each step, allowing the clinician to independently review and assess its relevance to the patient.

In this way, the CRS is designed to support the clinician throughout the decision-making process. The clinician remains responsible for evaluating the information presented and exercising independent professional judgment at the point of care.

Kanza has developed its Clinical Reasoning System with a focus on helping healthcare professionals navigate clinical complexity more efficiently and support informed clinical decision-making.

Kanza AI builds clinical reasoning AI for physicians at the point of care, co-developed with clinicians, trained on proprietary longitudinal clinical data and deployable across cloud and sovereign — on-prem or air-gapped — environments. The company is in live clinical use across institutions in the US, is a member of the NVIDIA Inception Program, and was selected by Google in 2026 as top-tier Scale AI in Health. Kanza was founded in Silicon Valley by Samir Arora, with co-founders Jeet Kaul, Sal Arora, Raj Narayan, and Dr. Toby Cosgrove, former CEO of Cleveland Clinic. Learn more at kanza.ai.

Media Contact: Elizabeth Larson info@kanza.ai